Navigation Links
Opioid use to relieve pain and suffering at end of life is safe in hospital-at-home setting
Date:9/9/2010

New Rochelle, NY, September 9, 2010Patients who choose to spend their last days at home with specialized care and monitoring can safely be given opioids to control pain and other symptoms without reducing survival time, according to a study published in Journal of Palliative Medicine (JPM), a peer-reviewed journal from Mary Ann Liebert, Inc.(www.liebertpub.com). The article is available free online at www.liebertpub.com/jpm

The use of high-dose opioids to relieve symptoms such as pain and shortness of breath in hospital- or hospice-based end-of-life care is proven to be effective but is available in only a few countries in the world. Many physicians around the world are afraid to prescribe opioids in sufficient doses to be effective in terminally ill patients in the home setting. Consequently, it is important that Itxaso Bengoechea, MD and colleagues from Galdakao-Usnsolo Hospital in Bizkaia, Spain, conducted a retrospective study on the safety and survival effects of increasing doses of opioids during end-of-life care at home. The study included 223 patients with terminal cancer who received specialized medical and nursing care and active monitoring in their homes.

The authors report that opioid use is both safe and effective and, in fact, patients who received a greater than two-fold increase in their initial dose had a longer median survival (22 days) than those who received lower doses (9 days). In the article entitled "Opioid Use at the End of Life and Survival in a Hospital at Home Unit," the authors conclude that opioid use in the home setting did not have a negative effect on patient survival time.

"Many worry that use of opioids in end-of-life care tacitly hastens death. Reassuringly, the results of this study show that higher doses were safe in the home and linked to longer survival," says Charles F. von Gunten, MD, PhD, Editor-in-Chief of Journal of Palliative Medicine and Provost, Institute for Palliative Medicine at San Diego Hospice.


'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Related biology news :

1. Higher opioid dose linked to overdose risk in chronic pain patients
2. A massage is proven to relieve psychophysiological state of patients with chronic headache
3. UB specialized exercise regimen shown to relieve prolonged concussion symptoms
4. Study shows pine bark naturally relieves symptoms of acute hemorrhoids
5. Arid aquaculture among livelihoods promoted to relieve worsening pressure on worlds drylands
6. New insights into treatment options for patients suffering from severe alcoholic hepatitis
7. New infant formula safety advice could prevent infant suffering
8. Common house ants form supercolonies, prosper in urban settings
9. Paleontologists find extinction rates higher in open-ocean settings during mass extinctions
10. Troublesome green algae serve as coating substrate in record-setting battery
11. Molecular typesetting -- proofreading without a proofreader
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
(Date:3/24/2017)... Research and Markets has announced the addition ... Trends - Industry Forecast to 2025" report to their offering. ... The Global Biometric ... of around 15.1% over the next decade to reach approximately $1,580 ... market estimates and forecasts for all the given segments on global ...
(Date:3/22/2017)... Optimove , provider of the ... as 1-800-Flowers and AdoreMe, today announced two new ... Using Optimove,s machine learning algorithms, these features allow ... recommendations to their customers based not just on ... intent drawn from a complex web of data ...
Breaking Biology News(10 mins):
(Date:7/24/2017)... ... , ... Charm Sciences, Inc. is pleased to announce the Charm® ROSA® Tetracycline-SL ... Shipments (NCIMS) Laboratory Committee and Appendix N Committee as a drug residue test kit ... NCIMS voted at its annual meeting in April, 2015 to establish a pilot program ...
(Date:7/20/2017)... Irvine, Calif. (PRWEB) , ... July 20, 2017 ... ... James G. Fujimoto, Ph.D ., the Elihu Thomson Professor of Electrical Engineering ... Beckman-Argyros Vision Research Award winner. Presented annually, the award recognizes an individual ...
(Date:7/20/2017)... AR (PRWEB) , ... July 20, 2017 , ... ... Rogers is joining the company’s board of directors. This addition continues to strengthen ... board," said Calvin Goforth, CEO and Chairman. “He is a highly accomplished business executive ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... clinical trial sites and study participants truly unified. TrialKit, a native mobile app, ... CFR Part 11) research studies entirely on mobile devices. With TrialKit, clinical researchers ...
Breaking Biology Technology: